AG18440/AG/NIA NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
2001	3
2002	5
2003	8
2004	8
2005	10
2006	3
2007	6
2008	12
2009	11
2010	21
2011	13
2012	21
2013	16
2014	15
2015	16
2016	4
2022	0

1

The many faces of α-synuclein: from structure and toxicity to therapeutic target.

Lashuel HA, Overk CR, Oueslati A, Masliah E. Lashuel HA, et al. Nat Rev Neurosci. 2013 Jan;14(1):38-48. doi: 10.1038/nrn3406. Nat Rev Neurosci. 2013. PMID: 23254192 Free PMC article. Review.

2

Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model.

Verret L, Mann EO, Hang GB, Barth AM, Cobos I, Ho K, Devidze N, Masliah E, Kreitzer AC, Mody I, Mucke L, Palop JJ. Verret L, et al. Cell. 2012 Apr 27;149(3):708-21. doi: 10.1016/j.cell.2012.02.046. Cell. 2012. PMID: 22541439 Free PMC article.

3

Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters.

Rockenstein E, Mallory M, Hashimoto M, Song D, Shults CW, Lang I, Masliah E. Rockenstein E, et al. J Neurosci Res. 2002 Jun 1;68(5):568-78. doi: 10.1002/jnr.10231. J Neurosci Res. 2002. PMID: 12111846

4

Autophagy in dementias.

Kragh CL, Ubhi K, Wyss-Coray T, Masliah E. Kragh CL, et al. Brain Pathol. 2012 Jan;22(1):99-109. doi: 10.1111/j.1750-3639.2011.00545.x. Brain Pathol. 2012. PMID: 22150925 Free PMC article. Review.

5

Cell-to-cell transmission of non-prion protein aggregates.

Lee SJ, Desplats P, Sigurdson C, Tsigelny I, Masliah E. Lee SJ, et al. Nat Rev Neurol. 2010 Dec;6(12):702-6. doi: 10.1038/nrneurol.2010.145. Epub 2010 Oct 12. Nat Rev Neurol. 2010. PMID: 21045796 Free PMC article. Review.

6

Novel strategies for Alzheimer's disease treatment.

Spencer B, Rockenstein E, Crews L, Marr R, Masliah E. Spencer B, et al. Expert Opin Biol Ther. 2007 Dec;7(12):1853-67. doi: 10.1517/14712598.7.12.1853. Expert Opin Biol Ther. 2007. PMID: 18034651 Review.

7

Immunotherapy for neurodegenerative diseases: focus on α-synucleinopathies.

Valera E, Masliah E. Valera E, et al. Pharmacol Ther. 2013 Jun;138(3):311-22. doi: 10.1016/j.pharmthera.2013.01.013. Epub 2013 Feb 4. Pharmacol Ther. 2013. PMID: 23384597 Free PMC article. Review.

8

Multiple system atrophy: a clinical and neuropathological perspective.

Ubhi K, Low P, Masliah E. Ubhi K, et al. Trends Neurosci. 2011 Nov;34(11):581-90. doi: 10.1016/j.tins.2011.08.003. Epub 2011 Sep 29. Trends Neurosci. 2011. PMID: 21962754 Free PMC article. Review.

9

Combination therapies: The next logical Step for the treatment of synucleinopathies?

Valera E, Masliah E. Valera E, et al. Mov Disord. 2016 Feb;31(2):225-34. doi: 10.1002/mds.26428. Epub 2015 Sep 21. Mov Disord. 2016. PMID: 26388203 Free PMC article. Review.

10

Biological transgenic mouse models of Alzheimer's disease.

Crews L, Rockenstein E, Masliah E. Crews L, et al. Handb Clin Neurol. 2008;89:291-301. doi: 10.1016/S0072-9752(07)01227-4. Handb Clin Neurol. 2008. PMID: 18631753 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results